Breaking News Instant updates and real-time market news.

TIF

Tiffany

$85.12

-0.89 (-1.03%)

16:51
12/10/18
12/10
16:51
12/10/18
16:51

Tiffany says JANA agrees to three director nominees for 2019 meeting

As previously disclosed, on December 6, Tiffany & Co.delivered notice, as required pursuant to that certain cooperation agreement, dated as of February 20, 2017, by and between JANA Partners and the Company, to JANA that the company will include each of Roger Farah, James Lillie and Francesco Trapani on the company's slate of director nominees for the 2019 Annual Meeting of Stockholders. On December 7, JANA agreed to the inclusion of these three directors on the slate for the 2019 Annual Meeting and therefore the Standstill Period will be extended, on and subject to the terms set forth in the Agreement, to the date that is thirty days prior to the expiration of the Company's advance notice period for the nomination of directors at the 2020 Annual Meeting of Stockholders. The remainder of the slate will be announced in the ordinary course in the Company's proxy statement for the 2019 Annual Meeting. In the interim, the company's board of directors is working with a leading search firm to identify additional qualified director candidates.

TIF Tiffany
$85.12

-0.89 (-1.03%)

11/29/18
RBCM
11/29/18
NO CHANGE
Target $105
RBCM
Sector Perform
Tiffany price target lowered to $105 from $132 at RBC Capital
RBC Capital analyst Brian Tunick lowered his price target on Tiffany to $105 and kept his Sector Perform rating after its Q3 results. The analyst says that the deceleration in comps growth and the management's comments around softer tourism activity from China have "reduced" his enthusiasm about the company's product and marketing initiatives heading into the holiday season. Tunick adds that the China tourism remarks add to his global growth concerns and expects the stock to trade range-bound in the near term because of the upcoming tougher comp compares.
11/29/18
GSCO
11/29/18
NO CHANGE
Target $136
GSCO
Buy
Tiffany price target lowered to $136 from $158 at Goldman Sachs
Goldman Sachs analyst Alexandra Walvis lowered her price target for Tiffany to $136 from $158 after the company posted a modest Q3 miss, largely driven by lighter comparable sales from lower tourist spend and higher SG&A as it invests for growth. While the analyst acknowledges tourism could remain a headwind in the near-term, she is encouraged by the continued underlying momentum the brand is experiencing with local consumers who are responding positively to new product, new marketing and new store environments. Walvis reiterates a Buy rating on the shares.
11/29/18
FBCO
11/29/18
NO CHANGE
Target $120
FBCO
Outperform
Tiffany price target lowered to $120 from $146 at Credit Suisse
Credit Suisse analyst Michael Binetti lowered his price target for Tiffany to $120 from $146 after the company reported disappointing same-store sales, largely driven by decelerating Chinese tourism. Nonetheless, the analyst thinks Tiffany remains one of the" most compelling self-help turnarounds" in his coverage and reiterates an Outperform rating on the shares.
11/29/18
MSCO
11/29/18
NO CHANGE
Target $96
MSCO
Equal Weight
Tiffany price target lowered to $96 from $126 at Morgan Stanley
Morgan Stanley analyst Kimberly Greenberger said Tiffany is executing "the best it can" and she is constructive on management's plans, but the great degree of volatility in its sales growth over the past 8 quarters is a signal to her that the macro environment is a greater determinant of its sales results than management strategies. Following the company's Q3 report, Greenberger lowered her 2018 EPS view slightly and cut her 2019 EPS estimate by about 8%, while lowering her price target on Tiffany shares to $96 from $126. She keeps an Equal Weight rating on the stock.

TODAY'S FREE FLY STORIES

BA

Boeing

$366.93

-2.57 (-0.70%)

05:15
11/20/19
11/20
05:15
11/20/19
05:15
Earnings
Boeing, Emirates announce order for 30 787 Dreamliner planes »

Boeing and Emirates…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AVAV

AeroVironment

$60.83

-0.81 (-1.31%)

05:14
11/20/19
11/20
05:14
11/20/19
05:14
Recommendations
AeroVironment analyst commentary  »

AeroVironment should…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 03

    Dec

  • 09

    Dec

NXTC

NextCure

$36.02

-0.23 (-0.63%)

05:11
11/20/19
11/20
05:11
11/20/19
05:11
Recommendations
NextCure analyst commentary  »

NextCure price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PCG

PG&E

$6.85

-0.22 (-3.11%)

05:10
11/20/19
11/20
05:10
11/20/19
05:10
Hot Stocks
PG&E shutting off power for about 150,000 customers in CA for PSPS »

Pacific Gas and Electric…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Jan

ZBRA

Zebra Technologies

$236.17

1.73 (0.74%)

05:09
11/20/19
11/20
05:09
11/20/19
05:09
Recommendations
Zebra Technologies analyst commentary  »

Zebra Technologies price…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CBOE

Cboe Global Markets

$122.53

2.01 (1.67%)

, TW

Tradeweb Markets

$43.26

-0.29 (-0.67%)

05:07
11/20/19
11/20
05:07
11/20/19
05:07
Downgrade
Cboe Global Markets, Tradeweb Markets rating change  »

Cboe Global Markets…

CBOE

Cboe Global Markets

$122.53

2.01 (1.67%)

TW

Tradeweb Markets

$43.26

-0.29 (-0.67%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TW

Tradeweb Markets

$43.26

-0.29 (-0.67%)

05:03
11/20/19
11/20
05:03
11/20/19
05:03
Upgrade
Tradeweb Markets rating change  »

Tradeweb Markets upgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BCO

Brink's

$90.04

0.515 (0.58%)

04:59
11/20/19
11/20
04:59
11/20/19
04:59
Initiation
Brink's initiated  »

Brink's initiated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BRY

Berry Petroleum

$8.90

-2.405 (-21.27%)

04:58
11/20/19
11/20
04:58
11/20/19
04:58
Downgrade
Berry Petroleum rating change  »

Berry Petroleum…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

KLAC

KLA-Tencor

$176.04

-0.95 (-0.54%)

04:55
11/20/19
11/20
04:55
11/20/19
04:55
Initiation
KLA-Tencor initiated  »

KLA-Tencor initiated with…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Dec

CBAY

CymaBay

$5.49

0.03 (0.55%)

, ALXN

Alexion

$110.65

2.71 (2.51%)

04:55
11/20/19
11/20
04:55
11/20/19
04:55
Conference/Events
Stifel to hold a conference »

Healthcare Conference…

CBAY

CymaBay

$5.49

0.03 (0.55%)

ALXN

Alexion

$110.65

2.71 (2.51%)

CBIO

Catalyst Biosciences

$5.18

-0.105 (-1.99%)

QURE

uniQure

$54.98

1.87 (3.52%)

GTHX

G1 Therapeutics

$22.72

0.32 (1.43%)

HZNP

Horizon Pharma

$30.49

-0.23 (-0.75%)

IONS

Ionis Pharmaceuticals

$58.04

0.27 (0.47%)

SILK

Silk Road Medical

$36.28

-1.27 (-3.38%)

SAGE

Sage Therapeutics

$147.89

2.28 (1.57%)

KIN

Kindred Biosciences

$7.48

0.14 (1.91%)

ACOR

Acorda Therapeutics

$1.58

-0.04 (-2.48%)

MASI

Masimo

$153.27

3.34 (2.23%)

IRIX

Iridex

$1.91

-0.12 (-5.91%)

BSX

Boston Scientific

$42.63

0.34 (0.80%)

PRVL

Prevail Therapeutics

$12.49

1.45 (13.13%)

SUPN

Supernus

$21.76

-0.28 (-1.27%)

EVLO

Evelo Biosciences

$5.64

-0.6 (-9.62%)

HRC

Hill-Rom

$107.23

2.64 (2.52%)

SVRA

Savara

$0.91

0.0064 (0.71%)

AERI

Aerie Pharmaceuticals

$18.85

-0.16 (-0.84%)

TNDM

TNDM

CERS

Cerus

$4.32

-0.055 (-1.26%)

SBBP

Strongbridge Biopharma

$1.49

0.025 (1.71%)

INGN

Inogen

$71.23

1.46 (2.09%)

ALDX

Aldeyra

$6.02

0.16 (2.73%)

ZGNX

Zogenix

$45.70

0.71 (1.58%)

VIVE

Viveve

$3.33

0.31 (10.26%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Nov

  • 20

    Nov

  • 07

    Dec

  • 12

    Dec

  • 16

    Dec

GLOP

GasLog Partners

$15.49

-1.01 (-6.12%)

04:55
11/20/19
11/20
04:55
11/20/19
04:55
Conference/Events
GasLog Partners management to meet with Jefferies »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Nov

  • 21

    Nov

  • 22

    Nov

ECL

Ecolab

$189.44

-1.84 (-0.96%)

04:55
11/20/19
11/20
04:55
11/20/19
04:55
Conference/Events
Ecolab management to meet with Jefferies »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Nov

  • 21

    Nov

MMI

Marcus & Millichap

$35.91

0.17 (0.48%)

04:55
11/20/19
11/20
04:55
11/20/19
04:55
Conference/Events
Marcus & Millichap management to meet with JMP Securities »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Nov

PSNL

Personalis

$8.89

(0.00%)

04:55
11/20/19
11/20
04:55
11/20/19
04:55
Conference/Events
Personalis management to meet with Oppenheimer »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Nov

AMSF

Amerisafe

$67.03

1.54 (2.35%)

04:55
11/20/19
11/20
04:55
11/20/19
04:55
Conference/Events
Amerisafe management to meet with B. Riley FBR »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Nov

04:55
11/20/19
11/20
04:55
11/20/19
04:55
Conference/Events
Clarion Events to hold a conference »

PowerGen International to…

04:55
11/20/19
11/20
04:55
11/20/19
04:55
General news
Breaking General news story  »

Week of 11/15 MBA…

EVER

EverQuote

$29.65

1.11 (3.89%)

04:55
11/20/19
11/20
04:55
11/20/19
04:55
Conference/Events
EverQuote management to meet with Oppenheimer »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Nov

  • 21

    Nov

  • 09

    Dec

  • 09

    Dec

04:55
11/20/19
11/20
04:55
11/20/19
04:55
General news
Breaking General news story  »

Week of 11/15 EIA…

TCDA

Tricida

$37.17

2.95 (8.62%)

04:55
11/20/19
11/20
04:55
11/20/19
04:55
Conference/Events
Tricida participates in a conference call with JPMorgan »

SMid Biotech Analyst Fye…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Nov

RDNT

RadNet

$17.61

-0.2 (-1.12%)

, GCI

Gannett

$9.67

-0.01 (-0.10%)

04:55
11/20/19
11/20
04:55
11/20/19
04:55
Hot Stocks
RadNet to replace Gannett in S&P 600 at open on 11/20 »

New Media Investment…

RDNT

RadNet

$17.61

-0.2 (-1.12%)

GCI

Gannett

$9.67

-0.01 (-0.10%)

NEWM

New Media

$6.29

-0.035 (-0.55%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AVD

American Vanguard

$14.60

-0.38 (-2.54%)

04:55
11/20/19
11/20
04:55
11/20/19
04:55
Conference/Events
American Vanguard management to meet with Loop Capital »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Nov

  • 11

    Dec

IMXI

International Money Express

$13.68

0.14 (1.03%)

04:55
11/20/19
11/20
04:55
11/20/19
04:55
Conference/Events
International Money Express management to meet with BTIG »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Nov

CHE

Chemed

$421.00

6.3 (1.52%)

04:55
11/20/19
11/20
04:55
11/20/19
04:55
Conference/Events
Chemed management to meet with Oppenheimer »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Nov

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.